<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ijcs</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Cardiovascular Sciences</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Int. J. Cardiovasc. Sci.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2359-4802</issn>
      <issn pub-type="epub">2359-5647</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">gcSwmKfPd5HkH85nXfxcNqD</article-id>
      <article-id specific-use="previous-pid" pub-id-type="publisher-id">S2359-56472021005010210</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S2359-56472021000400358</article-id>
      <article-id pub-id-type="publisher-id">ijcs.20210068</article-id>
      <article-id pub-id-type="doi">10.36660/ijcs.20210068</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Accuracy of the Simplified Version of the Global Risk Score in Detecting Cardiovascular Risk in Women from Quilombola Communities in the State of Alagoas, Brazil</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-1931-7695</contrib-id>
          <name>
            <surname>Cavalcante</surname>
            <given-names>Andressa Lima</given-names>
          </name>
          <bio>
            <p>
              <alternatives>
                <inline-graphic xlink:href="https://minio.scielo.br/documentstore/2359-5647/gcSwmKfPd5HkH85nXfxcNqD/c4e5f1fe4be5cce5c96a2bf5f54a02a7db1b5c69.tif"/>
                <inline-graphic xlink:href="https://minio.scielo.br/documentstore/2359-5647/gcSwmKfPd5HkH85nXfxcNqD/fd580bfa346e9a4e07bcf25806d1a662b0b01027.png" specific-use="scielo-web"/>
              </alternatives>
            </p>
            <p>Andressa Lima Cavalcante, Nurse, MSc</p>
            <p>Technique of the Center for Strategic Information and Response in Health Surveillance</p>
            <p>State Department of Health of Alagoas</p>
          </bio>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-1789-3138</contrib-id>
          <name>
            <surname>Ferreira</surname>
            <given-names>Haroldo da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <aff id="aff1">
          <institution content-type="orgname">Faculty of Nutrition of the Federal University of Alagoas</institution>
          <addr-line>
            <named-content content-type="city">Macei&#243;</named-content>
            <named-content content-type="state">AL</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Faculty of Nutrition of the Federal University of Alagoas, Macei&#243;, AL &#8211; Brazil.</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Mailing Address: Haroldo da Silva Ferreira</bold> Av. Pilar, 550. Postal Code: <postal-code>57038-430</postal-code>, Cruz das Almas, Macei&#243;, AL - Brazil. E-mail: <email>haroldo.ufal@gmail.com</email></corresp>
        <fn fn-type="con">
          <p>
            <bold>Author Contributions</bold>
          </p>
          <p>Conception and design of the research: Cavalcante AL and Ferreira HS. Acquisition of data: Cavalcante AL and Ferreira HS. Analysis and interpretation of the data: Cavalcante AL and Ferreira HS. Statistical analysis: Cavalcante AL and Ferreira HS. Obtaining financing: Ferreira HS. Writing of the manuscript: Cavalcante AL and Ferreira HS. Critical revision of the manuscript for intellectual content: Cavalcante AL and Ferreira HS. First author master's advisor: Ferreira HS.</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potential Conflict of Interest</bold>
          </p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>19</day>
        <month>07</month>
        <year>2021</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <season>Jul-Aug</season>
        <year>2021</year>
      </pub-date>
      <volume>34</volume>
      <issue>4</issue>
      <fpage>358</fpage>
      <lpage>368</lpage>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>03</month>
          <year>2021</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>04</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>05</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xml:lang="en" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background:</title>
          <p>Cardiovascular risk (CVR) monitoring is important for defining preventive actions against cardiovascular disease; this condition prevails more intensely in scenarios with less infrastructure such as African descent communities. The Framingham Risk Score (FRS) and the Global Risk Score (GRS) have been used in Brazil for CVR monitoring based on scales of points for certain risk factors. Among these, hypercholesterolemia and low high-density lipoprotein cholesterol require tests not always available in primary care. An alternative would be the simplified GRS (sGRS), in which these tests are replaced by the body mass index (kg/m<sup>2</sup>).</p>
        </sec>
        <sec>
          <title>Objective:</title>
          <p>To determine the accuracy of the sGRS in estimating CVR in African descent women (quilombolas) from Alagoas.</p>
        </sec>
        <sec>
          <title>Method:</title>
          <p>This is a cross-sectional study with a representative sample (n=1015) of women from African descent communities in Alagoas. GRS, sGRS, and FRS consisted in the sum of points obtained according to their respective scales. Receiver operating characteristic curves were used to compare the accuracy of these instruments as CVR predictors, assuming the GRS as reference. Statistical significance was assumed when p&lt;0.05.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>The prevalence of high CVR assessed with the GRS or sGRS was similar (20.1% vs. 20.7%; p&gt;0.05) and higher than that found with the FRS (4.5%; p&lt;0.001). Considering the area under the curve (AUC), the sGRS had a higher discriminatory power (AUC=0.98; 95%CI: 0.98&#8211;0.99) than the FRS (AUC=0.91; 95%CI: 0.90&#8211;0.93).</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>Among black women living in regions with less infrastructure, the sGRS produced similar results to the GRS, with greater operational simplicity.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords:</title>
        <kwd>Cardiovascular Diseases</kwd>
        <kwd>Risk Factors</kwd>
        <kwd>Epidemiology</kwd>
        <kwd>African Continental Ancestry Group</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source><italic>Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico</italic> - CNPq (National Council for Scientific and Technological Development)</funding-source>
          <award-id>442063/2014-8</award-id>
          <award-id>466718/2014-4</award-id>
        </award-group>
        <award-group>
          <funding-source><italic>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Alagoas</italic> &#8211; FAPEAL (Research Support Foundation of the State of Alagoas)</funding-source>
          <award-id>60030.000849/2016</award-id>
        </award-group>
        <funding-statement>This study was partially funded by <italic>Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico</italic> - CNPq (National Council for Scientific and Technological Development), processes 442063/2014-8 e 466718/2014-4, and <italic>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Alagoas</italic> &#8211; FAPEAL (Research Support Foundation of the State of Alagoas), process 60030.000849/2016).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="3"/>
        <equation-count count="0"/>
        <ref-count count="36"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Cardiovascular diseases (CVD) are currently the leading cause of death in Brazil and worldwide, justifying the implementation of prevention measures against this public health problem. In this sense, cardiovascular risk (CVR) monitoring allows the establishment of priorities among activities that focus on the CVD problem, assisting in the definition of practices and prognostic analyses. Several algorithms and scores are used to assess CVR, but none have been validated for the Brazilian population, even less so for the country&#8217;s black population.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref> Therefore, there is no consensus on which procedure would be the most appropriate for this purpose.</p>
      <p>The Brazilian Ministry of Health has recommended the Framingham Risk Score (FRS), which is intended to estimate CVR for the most severe forms of coronary artery disease (CAD). The Brazilian Society of Cardiology has recommended the Global Risk Score (GRS) to verify the 10-year risk of developing any atherosclerotic disease events.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref></p>
      <p>Both the FRS and GRS calculations require total cholesterol (TC) and high-density lipoprotein (HDL) data from patients, which are not always available in low-infrastructure settings. However, a simplified version of the GRS replaces these biochemical data with the body mass index (BMI). The simplified GRS (sGRS), by using measures that are easier to obtain, could thus be a better alternative for use in basic health units.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
      <p>All these instruments (FRS, GRS, and sGRS) derive from the Framingham Heart Study and are based on the synergism between risk factors for CVD. Therefore, their use is intended to estimate the risk of developing cardiovascular events.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref></p>
      <p>CVD affects individuals from lower-income populations more severely since they are more exposed to the different risk factors. In Brazil, the black population and particularly the quilombola population, due to institutional racism, remains historically at lower socioeconomic levels; this situation increases risks associated with CVD.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref></p>
      <p>Given the absence of studies on the accuracy of CVR indicators for the Brazilian population, especially for the black population, this study aimed to investigate the accuracy of the FRS and sGRS, using the GRS as reference. Additionally, we described the prevalence of risk factors for CVD in quilombola women from Alagoas.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>This work is part of the project entitled II Diagn&#243;stico de sa&#250;de e Seguran&#231;a Alimentar e Nutricional das fam&#237;lias das comunidades remanescentes dos quilombos do estado de Alagoas, approved by the Research Ethics Committee of Universidade Federal de Alagoas (CAAE No. 33527214.0.0000.5013).</p>
      <p>This is a cross-sectional study; data collection was performed from April 2017 to January 2018. The prevalence of high CVR in quilombola communities was considered as the variable of interest to estimate sample size. Since no previous studies had been conducted in Alagoas, the 6% prevalence found in the state of Maranh&#227;o was used.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> In 2015, around 6465 families were living in quilombola communities in Alagoas. Assuming that each family had one female member, 6465 women were the universe of interest of this research.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref> Using the StatCalc tool of Epi Info&#174; 7.2.1.0 and admitting a sampling error of 1.5% for a 95% confidence interval (CI), 861 women would be required for this study. In order to compensate for possible sample losses, this number was increased by 10%, totaling 948 women.</p>
      <p>In order to achieve this sample number, we randomly chose 34 out of the 68 existing quilombola communities. Women aged between 19 and 59 years from all households in the selected communities were eligible for the study. When there were 2 or more women in the same household, the participating woman was randomly defined. Exclusion criteria were being pregnant or in puerperium, having ingested alcoholic beverages in the last 24 hours, and presenting evident anatomical alterations.</p>
      <p>Data collection was performed by interviewers who were properly trained for executing their activities, which occurred under constant supervision. The pilot study used to standardize procedures and test instruments took place before the fieldwork began and was conducted in a community that was not selected for the main study.</p>
      <p>Data were collected through interviews using structured forms during home visits. Blood pressure and anthropometric measurements were also obtained. Subsequently, the women were referred to a previously defined place in the community for biochemical tests.</p>
      <p>The following variables were obtained for the socioeconomic and demographic characterization of our sample: self-reported skin color (black/brown; other); age group (19 to 39.9; 40 to 49.9; &#8805; 50 years); education (&lt; 4; &#8805; 4 years of study); marital status (single; stable relationship; widowed/separated); occupation (not working; farming; other); social class<xref ref-type="bibr" rid="B8"><sup>8</sup></xref> (B+C; D+E; there were no families in class A); participation in the Bolsa Fam&#237;lia Program (yes; no); and classification according to the Brazilian Food Insecurity Scale (EBIA), which classifies families as being in situations of mild, moderate, or severe food insecurity.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref></p>
      <p>Regarding health and lifestyle variables, the following conditions were defined: optimal blood pressure (BP), normal BP, prehypertension, and hypertension stages I, II, and III; normoglycemia, pre-diabetes mellitus, and diabetes mellitus (DM); smoking; low body weight, eutrophic, overweight, and obesity grades I, II, and III.</p>
      <p>Optimal BP was defined by systolic blood pressure (SBP) &lt; 120 mmHg and diastolic blood pressure (DBP) &lt; 80 mmHg; normal BP was considered as: SBP 120&#8211;129 mmHg and DBP 80&#8211;84 mmHg; prehypertension: SBP 130&#8211;139 mmHg and/or DBP 85&#8211;89 mmHg; systemic arterial hypertension (SAH) : SBP &#8805; 140 mmHg and/or DBP &#8805; 90 mmHg or when the use of antihypertensive medications was reported; stage I SAH: SBP 140&#8211;159 mmHg and/or DBP 90&#8211;99 mmHg; stage II SAH: SBP 160&#8211;179 mmHg and DBP 100&#8211;109 mmHg; stage III SAH: SBP &#8805; 180 mmHg and DBP &#8805; 110 mmHg.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> SBP and DBP measurements were performed in duplicates, according to the Brazilian Guidelines of Hypertension.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> An Omron&#174; Hem-7200 portable equipment was used, being periodically calibrated according to the manufacturer&#8217;s recommendations. If differences greater than 20 mmHg were observed between the 2 measurements, a third measurement was performed and the most discrepant result was disregarded. The mean of the 2 valid measurements was used in the analysis.</p>
      <p>Prediabetes and DM were defined by glycated hemoglobin (HbA1c) levels between 5.7% and 6.4% and &#8805; 6.5%, in that order.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> Hypercholesterolemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol (HDL-c) were determined by the following conditions (mg/dL): low-density lipoprotein (LDL) &#8805; 160, triglycerides &#8805; 175, and HDL &lt; 50, respectively.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Dyslipidemia was designated when at least one of these lipid profile alterations was found.</p>
      <p>In addition to the biochemical reference values, the use of hypoglycemic drugs or medications to control lipid alterations was also a criterion for defining these conditions.</p>
      <p>TC, HDL, and HbA1c measurements were performed using a drop of blood obtained by puncturing the digital pulp, regardless of fasting.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref> These determinations were performed using an Alere Cholestech LDX&#174; System and, in the case of HbA1C, an Alere NycoCard Reader II&#174;, with their respective analysis cassettes.</p>
      <p>Smoking was identified as the consumption of tobacco products in the last 3 months and assessed through the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST), validated for the Brazilian population.<xref ref-type="bibr" rid="B13"><sup>13</sup></xref></p>
      <p>Nutritional status classifications were based on the BMI according to the following categories<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>: underweight (&lt; 18.5 kg/m&#178;); eutrophic (18.5&#8211;24.9 kg/m&#178;); overweight (25&#8211;29.9 kg/m&#178;); obesity grade I (30&#8211;34.9 kg/m&#178;); obesity grade II (35&#8211;39.9 kg/m&#178;); and obesity grade III (&#8805; 40 kg/m&#178;). The weight and height of the participant were measured for calculating the BMI. Body mass was obtained using a digital scale (model 813, Seca&#174;) with a 200 kg capacity. A portable stadiometer (model 213, Seca&#174;) was used to measure the participants&#8217; height.</p>
      <p>The GRS was used as reference for evaluating the accuracy of FRS and sGRS in predicting CVR. The GRS is determined by attributing points to age, waist circumference, HDL, systolic blood pressure, smoking, and DM variables, as shown in the table presented in the original publication.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref> The CVR was classified as follows: &#8804; 8 points (low risk); 9 to 12 points (intermediate risk); and &#8805; 13 points (high risk).<xref ref-type="bibr" rid="B2"><sup>2</sup></xref></p>
      <p>The FRS was proposed in 2001 aiming to identify individuals at high risk for atherogenesis and those who were more likely to develop severe forms of CAD when the atherosclerosis process was already established.<xref ref-type="bibr" rid="B15"><sup>15</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref> Variables constituting the FRS are age, TC, HDL, smoking, SBP, and use of antihypertensive medication; our scores were established as presented in the original publication.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref> The FRS was classified as follows: &#8804; 19 points (low risk); 20 to 22 points (intermediate risk); and &#8805; 23 points (high risk).<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> This classification was proposed by the Brazilian Ministry of Health and favors specificity over sensitivity. In order to avoid this problem, in this study the sum of "intermediate risk" and "high risk" conditions was regarded as high CVR.</p>
      <p>As mentioned previously, the sGRS is a simplification in which the procedures of the original GRS were maintained, but TC and HDL data were replaced by the BMI.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
      <sec>
        <title>Statistical analysis</title>
        <p>Data entry was performed by independent double entry on forms generated by Epi Info&#174; 7.2.1.0. Databases were compared to identify and correct typing errors.</p>
        <p>A descriptive analysis was performed on the prevalence of high CVR according to the 3 protocols (GRS, sGRS, and FRS), demographic aspects, socioeconomic status, and health conditions. The measure of association was the prevalence ratio (PR) and its respective 95% CIs, calculated by the Poisson regression with robust variance adjustment.</p>
        <p>The receiver operating characteristic (ROC) curve was used to evaluate the accuracy of sGRS and FRS as predictors of CVR using the GRS as reference. Areas under the curve (AUCs) were calculated for each of the evaluated scores using the DeLong test. The Youden index (J) was calculated using the formula J = (sensitivity + specificity) &#8211; 1 to define the best cut-off points (CPs), which considered the highest value of J. Subsequently, sensitivity and specificity were compared according to the best CPs or the originally proposed ones.</p>
        <p>Statistical analyses were performed using Stata&#174; 12.0 and, in all situations, statistical significance was assumed when p &lt; 0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>Our sample consisted of 1015 women. Most of them had black or brown skin, 4 or more years of study, a stable marital relationship, belonged to the lowest economic class, were in a situation of food insecurity, and were contemplated by the Bolsa Fam&#237;lia Program. Other sociodemographic characteristics are presented in <xref ref-type="table" rid="t1">Table 1</xref>.</p>
      <table-wrap id="t1">
        <label>Table 1</label>
        <caption>
          <title>Characterization of demographic, socioeconomic, and health conditions of women from remaining quilombola communities in the state of Alagoas, 2018.</title>
        </caption>
        <table frame="hsides" rules="rows">
          <colgroup width="33%">
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
            <tr style="background-color:#BCBDC0">
              <th align="left" valign="middle">Characteristics</th>
              <th align="center" valign="middle">Sample <xref ref-type="table-fn" rid="TFN1">a</xref></th>
              <th align="center" valign="middle">n (%)</th>
            </tr>
          </thead>
          <tbody style="border-bottom: thin solid; border-color: #000000">
            <tr>
              <td align="left" valign="middle">Self-reported skin color</td>
              <td align="center" valign="middle">1013</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Black + brown</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">922 (91.0)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Others</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">91 (9.0)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Education (years)</td>
              <td align="center" valign="middle">1011</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">&lt; 4</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">369 (36.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">&#8805; 4</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">642 (63.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Marital status</td>
              <td align="center" valign="middle">1015</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Single</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">129 (12.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Stable relationship</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">799 (78.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Others (widowed, divorced)</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">87 (8.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Social class <xref ref-type="table-fn" rid="TFN2">b</xref></td>
              <td align="center" valign="middle">1015</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">B+C</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">59 (5.8)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">D+E</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">956 (94.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Food security <xref ref-type="table-fn" rid="TFN3">c</xref></td>
              <td align="center" valign="middle">1001</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Food security</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">260 (26.0)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Mild insecurity</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">324 (32.4)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Moderate insecurity</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">241 (24.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Severe insecurity</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">176 (17.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Food insecurity (all types)</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">741 (74.0)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Contemplated by the Bolsa Fam&#237;lia program</td>
              <td align="center" valign="middle">1007</td>
              <td align="center" valign="middle">741 (73.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Main occupation</td>
              <td align="center" valign="middle">1007</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Does not work</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">445 (44.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Family farming</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">335 (33.3)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Others <xref ref-type="table-fn" rid="TFN11">**</xref></td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">227 (22.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Systemic arterial hypertension <xref ref-type="table-fn" rid="TFN4">d</xref></td>
              <td align="center" valign="middle">1015</td>
              <td align="center" valign="middle">229 (22.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Diabetes mellitus <xref ref-type="table-fn" rid="TFN5">e</xref></td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">254 (25.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle"><bold>Excess weight</bold> (overweight + obesity; BMI &#8805; 25 kg/m<sup>2</sup>)</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">678 (66.8)</td>
            </tr>
            <tr>
              <td align="left" valign="middle"><bold>Hypercholesterolemia</bold> (LDL &#8805; 160 mg/dL) <xref ref-type="table-fn" rid="TFN10">f</xref></td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">102 (10.0)</td>
            </tr>
            <tr>
              <td align="left" valign="middle"><bold>Hypertriglyceridemia</bold> (triglycerides &#8805; 175 mg/dL) <xref ref-type="table-fn" rid="TFN10">f</xref></td>
              <td align="center" valign="middle">1014</td>
              <td align="center" valign="middle">299 (29.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle"><bold>Low HDL</bold> (HDL &lt; 50 mg/dL) <xref ref-type="table-fn" rid="TFN10">f</xref></td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">739 (72.8)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">CVR classification according to the Global Risk Score (GRS)<xref ref-type="table-fn" rid="TFN12">g</xref></td>
              <td align="center" valign="middle">1015</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Low</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">646 (63.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Intermediate</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">165 (16.3)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">High</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">204 (20.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">CVR classification according to the simplified GRS<xref ref-type="table-fn" rid="TFN13">h</xref></td>
              <td align="center" valign="middle">1015</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Low</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">652 (64.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Intermediate</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">153 (15.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">High</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">210 (20.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">CVR classification according to the Framingham Score<xref ref-type="table-fn" rid="TFN14">i</xref></td>
              <td align="center" valign="middle">1015</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Low</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">969 (95.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Intermediate</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">42 (4.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">High</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">4 (0.4)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Intermediate + High</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle">46 (4.5)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <label>a</label>
            <p>Sample size &lt; 1.015 due to missing information for the respective variable.</p>
          </fn>
          <fn id="TFN2">
            <label>b</label>
            <p>Brazilian economic classification criteria.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref></p>
          </fn>
          <fn id="TFN3">
            <label>c</label>
            <p>Brazilian Food Insecurity Scale.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref></p>
          </fn>
          <fn id="TFN4">
            <label>d</label>
            <p>Defined by systolic blood pressure &#8805; 140 mmHg and/or diastolic blood pressure &#8805; 90 mmHg or use of antihypertensive medication.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
          </fn>
          <fn id="TFN5">
            <label>e</label>
            <p>Glycated hemoglobin (HbA1c) &#8805; 6.5%.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref></p>
          </fn>
          <fn id="TFN6">
            <p>BMI = body mass index.<xref ref-type="bibr" rid="B14"><sup>14</sup></xref></p>
          </fn>
          <fn id="TFN7">
            <p>LDL: low-density lipoprotein.</p>
          </fn>
          <fn id="TFN8">
            <p>HDL: high-density lipoprotein.</p>
          </fn>
          <fn id="TFN9">
            <p>CVR: cardiovascular risk.</p>
          </fn>
          <fn id="TFN10">
            <label>f</label>
            <p>Faludi et al. 2017.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref></p>
          </fn>
          <fn id="TFN11">
            <label>**</label>
            <p>Formal worker, public servant, independent worker, self-employed, retired/pensioner, student, and fisherman-gatherer.</p>
          </fn>
          <fn id="TFN12">
            <label>g</label>
            <p>Pr&#233;coma and Oliveira (2019).<xref ref-type="bibr" rid="B2"><sup>2</sup></xref></p>
          </fn>
          <fn id="TFN13">
            <label>h</label>
            <p>D'Agostino et al. (2008).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
          </fn>
          <fn id="TFN14">
            <label>i</label>
            <p>Ministry of Health (2013).<xref ref-type="bibr" rid="B17"><sup>17</sup></xref></p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p><xref ref-type="table" rid="t1">Table 1</xref> also shows the prevalence of cardiovascular risk factors. A total of 22.6% women had hypertension, 25.1% had DM, and 66.8% were overweight (30.3% were obese). The most prevalent lipid alteration was low HDL, followed by hypertriglyceridemia and hypercholesterolemia.</p>
      <p>The prevalence of high CVR according to the GRS was 20.1%, which was similar to what was found with the sGRS (20.7%) and much higher than the number observed when using the FRS (4.5%), even when this latter classification grouped &#8220;intermediate risk&#8221; cases together with the "high risk" category.</p>
      <p>We observed a strong association between high CVR and risk factor categories (<xref ref-type="table" rid="t2">Table 2</xref>). The prevalence of this outcome showed increments ranging from 7.5 to 13.1 times in women presenting SAH stages I to III, respectively. Women with DM had a CVR almost 6 times higher than that of women without this metabolic alteration. Women with stage III obesity had an approximately 3 times higher CVR when compared with eutrophic women. Similar associations also occurred for hypercholesterolemia, hypertriglyceridemia, low HDL, and smoking. Women aged 40 to 49.9 years and those aged 50 or older had frequencies of the outcome of interest that were around 10 and 30 times higher, respectively, than that found in those under 40 years old.</p>
      <table-wrap id="t2">
        <label>Table 2</label>
        <caption>
          <title>Prevalence of high cardiovascular risk (CVR) according to the Global Risk Score, based on risk factors for cardiovascular diseases in women (n = 1015) from remaining quilombola communities in the state of Alagoas (2018)</title>
        </caption>
        <table frame="hsides" rules="rows">
          <colgroup width="25%">
            <col/>
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
            <tr style="background-color:#BCBDC0">
              <th align="left" valign="middle">Variable</th>
              <th align="center" valign="middle">n (%)</th>
              <th align="center" valign="middle">High CVR (%)</th>
              <th align="center" valign="middle">PR (CI 95%)</th>
            </tr>
          </thead>
          <tbody style="border-bottom: thin solid; border-color: #000000">
            <tr>
              <td align="left" valign="middle">
                <bold>
                  <italic>Classification according to blood pressure (mmHg)</italic>
                </bold>
                <xref ref-type="table-fn" rid="TFN16">A</xref>
              </td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
            <tr>
              <td align="left" valign="middle">Optimal BP (n = 410; 40.4%) + normal BP (n = 234; 23.0%)</td>
              <td align="center" valign="middle">644 (63.4)</td>
              <td align="center" valign="middle">6.5</td>
              <td align="center" valign="middle">1</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Prehypertension (SBP 130&#8211;139 and/or DBP 85&#8211;89)</td>
              <td align="center" valign="middle">142 (14.0)</td>
              <td align="center" valign="middle">21.8</td>
              <td align="center" valign="middle">3.3 (2.2&#8211;5.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Stage I (SBP 140&#8211;159 and/or DBP 90&#8211;99)</td>
              <td align="center" valign="middle">157 (15.5)</td>
              <td align="center" valign="middle">49.0</td>
              <td align="center" valign="middle">7.5 (5.4&#8211;10.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Stage II (SBP 160&#8211;179 and/or DBP 100&#8211;109)</td>
              <td align="center" valign="middle">51 (5.0)</td>
              <td align="center" valign="middle">70.6</td>
              <td align="center" valign="middle">10.8 (7.7&#8211;15.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Stage III (SBP &#8805; 180 mmHg and/or DBP &#8805; 110)</td>
              <td align="center" valign="middle">21 (2.1)</td>
              <td align="center" valign="middle">85.7</td>
              <td align="center" valign="middle">13.1 (9.4&#8211;18.5)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Total</td>
              <td align="center" valign="middle">
                <bold>1015 (100.0)</bold>
              </td>
              <td align="center" valign="middle">
                <bold>20.1</bold>
              </td>
              <td align="center" valign="middle">&#8211;</td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <bold>
                  <italic>Classification according to glycated hemoglobin (HbA1c %)</italic>
                </bold>
                <xref ref-type="table-fn" rid="TFN17">B</xref>
              </td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
            <tr>
              <td align="left" valign="middle">Normoglycemia (&lt; 5.7)</td>
              <td align="center" valign="middle">381 (37.6)</td>
              <td align="center" valign="middle">7.9</td>
              <td align="center" valign="middle">1</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Pre-diabetes mellitus (5.7&#8211;6.4)</td>
              <td align="center" valign="middle">378 (37.3)</td>
              <td align="center" valign="middle">14.0</td>
              <td align="center" valign="middle">1.78 (1.2&#8211;2.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Diabetes mellitus (&#8805; 6.5)</td>
              <td align="center" valign="middle">254 (25.1)</td>
              <td align="center" valign="middle">46.8</td>
              <td align="center" valign="middle">5.95 (4.1&#8211;8.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Total</td>
              <td align="center" valign="middle">1013 (100.0)</td>
              <td align="center" valign="middle">19.9</td>
              <td align="center" valign="middle">&#8211;</td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <bold>
                  <italic>Classification according to body mass index (kg/m<sup>2</sup>)</italic>
                </bold>
                <xref ref-type="table-fn" rid="TFN18">C</xref>
              </td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
            <tr>
              <td align="left" valign="middle">Low weight (n=20; 2.0%) + Eutrophic (n=317; 31.2%)</td>
              <td align="center" valign="middle">337 (33.2)</td>
              <td align="center" valign="middle">14.2</td>
              <td align="center" valign="middle">1</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Overweight (25&#8211;29.9)</td>
              <td align="center" valign="middle">371 (36.5)</td>
              <td align="center" valign="middle">20.2</td>
              <td align="center" valign="middle">1.42 (1.1&#8211;2.0)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Obesity level I (30&#8211;34.9)</td>
              <td align="center" valign="middle">217 (21.4)</td>
              <td align="center" valign="middle">27.6</td>
              <td align="center" valign="middle">1.94 (1.4&#8211;2.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Obesity level II (35&#8211;39.9)</td>
              <td align="center" valign="middle">65 (6.4)</td>
              <td align="center" valign="middle">16.9</td>
              <td align="center" valign="middle">1.19 (0.6&#8211;2.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Obesity level III (&#8805; 40)</td>
              <td align="center" valign="middle">25 (2.5)</td>
              <td align="center" valign="middle">40.0</td>
              <td align="center" valign="middle">2.81 (1.62&#8211;4.8)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Dyslipidemias</td>
              <td align="center" valign="middle">798 (78.7)</td>
              <td align="center" valign="middle">22.7</td>
              <td align="center" valign="middle">2.13 (1.4&#8211;3.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Hypercholesterolemia (LDL &#8805; 160 mg/dL)</td>
              <td align="center" valign="middle">102 (10.0)</td>
              <td align="center" valign="middle">44.1</td>
              <td align="center" valign="middle">2.53 (2.0&#8211;3.3)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Hypertriglyceridemia (triglycerides &#8805; 175 mg/dL)</td>
              <td align="center" valign="middle">299 (29.5)</td>
              <td align="center" valign="middle">37.1</td>
              <td align="center" valign="middle">2.85 (2.2&#8211;3.6)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Low HDL (HDL &lt; 50 mg/dL)</td>
              <td align="center" valign="middle">739 (72.8)</td>
              <td align="center" valign="middle">22.3</td>
              <td align="center" valign="middle">1.58 (1.1&#8211;2.2)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Smoking</td>
              <td align="center" valign="middle">225 (22.2)</td>
              <td align="center" valign="middle">45.3</td>
              <td align="center" valign="middle">3.51 (2.8&#8211;4.4)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <bold>Age group (years)</bold>
              </td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
            <tr>
              <td align="left" valign="middle">19&#8211;39.9</td>
              <td align="center" valign="middle">577 (56.9)</td>
              <td align="center" valign="middle">2.2</td>
              <td align="center" valign="middle">1</td>
            </tr>
            <tr>
              <td align="left" valign="middle">40&#8211;49.9</td>
              <td align="center" valign="middle">251 (24.7)</td>
              <td align="center" valign="middle">27.1</td>
              <td align="center" valign="middle">10.02 (6.8&#8211;21.4)</td>
            </tr>
            <tr>
              <td align="left" valign="middle">&#8805; 50</td>
              <td align="center" valign="middle">187 (18.4)</td>
              <td align="center" valign="middle">65.8</td>
              <td align="center" valign="middle">29.19 (16.9&#8211;50.5)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN15">
            <p>PR: prevalence ratio</p>
          </fn>
          <fn id="TFN16">
            <label>A</label>
            <p>Brazilian Guidelines of Arterial Hypertension.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> BP: blood pressure. SBP or DBP: systolic blood pressure or diastolic blood pressure.</p>
          </fn>
          <fn id="TFN17">
            <label>B</label>
            <p>Guidelines of the Brazilian Society of Diabetes 2017&#8211;2018.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref></p>
          </fn>
          <fn id="TFN18">
            <label>C</label>
            <p>World Health Organization, 2000.<xref ref-type="bibr" rid="B14"><sup>14</sup></xref></p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>As shown in <xref ref-type="fig" rid="f1">Figure 1</xref>, scales resulting from the FRS and sGRS showed excellent performance in predicting cardiovascular risk (AUC &gt; 0.9; p &lt; 0.001). However, the sGRS showed a higher discriminatory power than the FRS.</p>
      <fig id="f1">
        <label>Figure 1</label>
        <caption>
          <title>Areas under the receiver operating characteristic (ROC) curve (AUCs) regarding the ability to predict high cardiovascular risk when using the simplified Global Risk Score (sGRS) or the Framingham Risk Score (FRS), with the Global Risk Score (GRS) as reference. Study with women from remaining quilombola communities in the state of Alagoas, 2018.</title>
        </caption>
        <graphic xlink:href="2359-5647-ijcs-34-04-0358-10068-gf01.tif"/></fig>
      <p><xref ref-type="table" rid="t3">Table 3</xref> shows the best CPs found in this study, with a higher accuracy than that obtained with the originally proposed CPs, particularly for the FRS. The CP of 20, which defines intermediate- and high-risk conditions, presented a sensitivity of only 18.6%, with a very high specificity (99.0%). Using the CP of 9, established by the highest J index, sensitivity and specificity reached 98.0% and 69.0%, respectively. The prevalence of high CVR, with this change in CP, increased from 4.5% to 44.4%. Regarding the sGRS, when the CP for high CVR (CP &#8805; 13.0) was changed to the one with the best performance (CP &#8805; 11.0), sensitivity increased from 87.2% to 97.6%, although with a decrease in specificity (from 96.0% to 88.5%). When considering the best CP, the prevalence of high CVR increased from 20.7% to 28.8%.</p>
      <table-wrap id="t3">
        <label>Table 3</label>
        <caption>
          <title>Sensitivity (S), specificity (E), and prevalence of high cardiovascular risk (high CVR) obtained according to different cut-off points (CPs) applied to the simplified Global Risk Score (sGRS) and the Framingham Risk Score, with the Global Risk Score as reference. Study with women (n = 1015) from quilombola communities in the state of Alagoas, 2018</title>
        </caption>
        <table frame="hsides" rules="rows">
          <colgroup width="16%">
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
            <tr style="background-color:#BCBDC0">
              <th align="left" valign="middle">Score</th>
              <th align="center" valign="middle" colspan="2">CP</th>
              <th align="center" valign="middle">S (%)</th>
              <th align="center" valign="middle">E (%)</th>
              <th align="center" valign="middle">High CVR n (%)</th>
            </tr>
          </thead>
          <tbody style="border-bottom: thin solid; border-color: #000000">
            <tr>
              <td align="left" valign="middle" rowspan="2">sGRS <xref ref-type="table-fn" rid="TFN19">a</xref></td>
              <td align="center" valign="middle">Original CP <xref ref-type="table-fn" rid="TFN19">a</xref></td>
              <td align="center" valign="middle">13.0</td>
              <td align="center" valign="middle">87.2</td>
              <td align="center" valign="middle">96.0</td>
              <td align="center" valign="middle">210 (20.7)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">Best CP <xref ref-type="table-fn" rid="TFN21">c</xref></td>
              <td align="center" valign="middle">11.0 <xref ref-type="table-fn" rid="TFN22">d</xref></td>
              <td align="center" valign="middle">97.6</td>
              <td align="center" valign="middle">88.5</td>
              <td align="center" valign="middle">292 (28.8)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="2">Framingham Score <xref ref-type="table-fn" rid="TFN20">b</xref></td>
              <td align="center" valign="middle">Original CP <xref ref-type="table-fn" rid="TFN20">b</xref></td>
              <td align="center" valign="middle">20.0</td>
              <td align="center" valign="middle">18.6</td>
              <td align="center" valign="middle">99.0</td>
              <td align="center" valign="middle">46 (4.5)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">Best CP <xref ref-type="table-fn" rid="TFN21">c</xref></td>
              <td align="center" valign="middle">9.0 <xref ref-type="table-fn" rid="TFN23">e</xref><xref ref-type="table-fn" rid="TFN24">f</xref></td>
              <td align="center" valign="middle">98.0</td>
              <td align="center" valign="middle">69.0</td>
              <td align="center" valign="middle">451 (44.4)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN19">
            <label>a</label>
            <p>D&#8217;Agostino et al. (2008).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>;</p>
          </fn>
          <fn id="TFN20">
            <label>b</label>
            <p>Ministry of Health (2013).<xref ref-type="bibr" rid="B17"><sup>17</sup></xref></p>
          </fn>
          <fn id="TFN21">
            <label>c</label>
            <p>Based on the Youden index.</p>
          </fn>
          <fn id="TFN22">
            <label>d</label>
            <p>Rounded from 11.5 to 11.0 to contemplate only integer values, as in the original scale.</p>
          </fn>
          <fn id="TFN23">
            <label>e</label>
            <p>Consolidating the intermediate and high CVR categories to increase sensitivity.</p>
          </fn>
          <fn id="TFN24">
            <label>f</label>
            <p>Rounded from 8.5 to 9.0 to contemplate only integer values, as in the original scale.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>CVDs are currently the leading cause of mortality. Therefore, identifying individuals at higher risk is a critical task in public health to enable the adoption of preventive measures. It is important to have accurate and easy-to-operate tools to perform this identification. The results presented herein showed that the sGRS can be used instead of the GRS without any disadvantage. The latter is considered a more complete index because it includes biochemical data that indicate dyslipidemia, which are replaced by the BMI in the sGRS. The performance of the FRS compared to the GRS, although also satisfactory, was worse than that of the sGRS.</p>
      <p>When the proposed CPs are used to discriminate patients at high CVR with the FRS, sensitivity is very low (despite a high specificity), which results in a high number of false negatives; this condition is not appropriate for screening CVR for elaborating preventive actions. In this perspective, the GRS should be used and, in the absence of lipid profile data, the sGRS.</p>
      <p>Data routinely obtained in basic health units are used in the sGRS, thus this index can be widely applied even in contexts of poor infrastructure.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref> Among the information required for the sGRS, only the definition of DM is ideally performed by laboratory tests, which could be an obstacle. However, most Brazilian municipalities have implemented the Blood Glucose Self-Monitoring Program, which provides users with glucose testing supplies.<xref ref-type="bibr" rid="B18"><sup>18</sup></xref> Moreover, the identification of diabetes can be done by self-reporting or when the patient reports the use of hypoglycemic agents.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref></p>
      <p>The women followed in this study belonged to quilombola communities, which comprise a social group that is specially subjected to social inequities and survive in a scenario marked by a low socioeconomic status, poor environmental conditions, and a high prevalence of food insecurity and morbidities related to this context. These characteristics are not exclusive to the quilombola women of Alagoas (who our sample plan attempts to represent), being extended to the entire Afrodescendant Brazilian population.<xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref></p>
      <p>Some studies have shown a differential distribution of aggravations when comparing individuals from the quilombola population with those not from this population. Silva et al.<xref ref-type="bibr" rid="B21"><sup>21</sup></xref> investigated the prevalence of food insecurity in 21 rural communities located in the northeast region of Brazil, 9 of which were quilombolas. A prevalence of 64.9% was observed among quilombolas and a prevalence of 42% was found in the other communities, demonstrating the greater social vulnerability of this population.</p>
      <p>Using representative samples of quilombola (n = 1631) and non-quilombola (n = 1098) women from the state of Alagoas, Ferreira et al.<xref ref-type="bibr" rid="B22"><sup>22</sup></xref> found that among quilombola women, overweight (50.1% vs 44.2%), body fat percentages &gt; 33% (37.1% vs 23.3%), abdominal obesity (53.5% vs 34.3%), and hypertension (34.9% vs 11.4%) predominated in higher proportions. They concluded that quilombola women had a lower socioeconomic level and were more exposed to risk factors, which makes them more susceptible to morbidity and mortality from CVDs and justifies a prioritized attention by public policies.</p>
      <p>Due to precarious living conditions, this population would have difficulties in adopting a healthy lifestyle. Regarding their diet, the consumption of ultra-processed foods, which are rich in sodium and poor in nutrients, may be one of the causes of a high prevalence of hypertension.<xref ref-type="bibr" rid="B23"><sup>23</sup></xref> In our study, most women with high CVR had SAH.</p>
      <p>Corroborating the results of previous studies, in this study we observed a high prevalence of high CVR in smokers and obese individuals, which are conditions that are potentially reversible by a timely approach in primary care.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref></p>
      <p>In addition to the risk factors traditionally involved in CVD pathogenesis, it is well known that the racial-ethnic segment investigated by this study faces institutional and personal racism, which constitutes a traumatic event that causes low self-esteem and stress that in turn affect the cardiovascular and hemodynamic conditions and may increase exposure to unhealthy behaviors.<xref ref-type="bibr" rid="B25"><sup>25</sup></xref><sup>&#8211;</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> Incidentally, a previous study with this population showed a high prevalence (65.3%) of common mental disorders.<xref ref-type="bibr" rid="B29"><sup>29</sup></xref> In the non-quilombola population of Alagoas, this prevalence was 47.9%.<xref ref-type="bibr" rid="B30"><sup>30</sup></xref></p>
      <p>In Brazil, the "Reorganization Care Plan for Hypertension and Diabetes Mellitus," implemented in 2001, targeted prevention and treatment at the primary health care level. Nevertheless, the identification of CVR was limited to the presence of risk factors and/or target organ damage.<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> Subsequently, it was recommended that CVR assessment be carried out by means of multivariable models, adopting risk identification tools based on the Framingham study.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref></p>
      <p>Among the CVR identification methods evaluated in this study, the FRS using the CP proposed by the Ministry of Health (CP &#8805; 20) showed low sensitivity (18.6%) but 99.9% specificity. As mentioned previously, this is not a good performance for a screening instrument, since it results in many false negatives. Based on the ROC curve, we observed that a CP of 9.0 would result in the highest accuracy. Using this new cutoff resulted in sensitivity and specificity values closer to those observed with the sGRS. This index, in turn, would have better accuracy in identifying high CVR in the studied population if the original CP (CP &#8805; 13.0) were to be changed for the one defined in this study (CP &#8805; 11.0) because its sensitivity would increase from 87.2% to 97.6%, although with a reduction in specificity from 96.0% to 88.5%.</p>
      <p>In addition, regarding the low sensitivity observed when using the original cutoff point for the FRS (CP &#8805; 20.0), it can be speculated that this is because this protocol was based on a subgroup of atherosclerotic diseases, requiring adjustment to assess CVR in a global scale. This reinforces the relevance of using the sGRS in primary health care. In line with our findings, a study that compared the performance of the GRS and sGRS in predicting CVR in a sample consisting of Black and White Americans<xref ref-type="bibr" rid="B33"><sup>33</sup></xref> concluded that both indexes found similar results. Therefore, the sGRS may be an alternative for initial screenings aiming at appropriate cardiovascular health care considering cost optimization.</p>
      <p>Therefore, the efficient management of CVR depends on the access to health services, qualified professional care, and self-care.<xref ref-type="bibr" rid="B34"><sup>34</sup></xref> The quilombola communities face political and operational difficulties, since the nearest health services usually have inadequate infrastructure, limited and fragmented care, and few human and material resources.<xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B36"><sup>36</sup></xref> Moreover, the adoption of healthy lifestyle habits also depends on the professional approach, which must consider the peculiarities of these individuals, including their beliefs.<xref ref-type="bibr" rid="B34"><sup>34</sup></xref></p>
      <sec>
        <title>Limitations of the study</title>
        <p>Since this was a cross-sectional study, we worked with prevalence and not incidence. It would be interesting to obtain results from longitudinal studies, in which it would be possible to obtain this parameter according to whether or not the individuals presented high CVR at the beginning of the study.</p>
        <p>The representativeness of our results for the state of Alagoas should be regarded with some caution, since the sample calculation used the prevalence of high CVR observed in another state. However, a calculation performed a posteriori, considering our sample size (n = 1015) and the observed prevalence (20.1%), indicated a sampling error of 2.3% (0.8% higher than planned), which is a widely accepted value in population-based epidemiologic surveys.</p>
        <p>Another limitation was the fact that we did not analyze CVR in men. This occurred because this study was part of a larger project whose operationalization involved the displacement of researchers to places of difficult access, which were distant from the state capital. Data collection took place during business hours from Monday to Friday, when most of the men in the community were working and, therefore, away from home. Consequently, our male sample was not only small, but also presented many losses, rendering the analysis unfeasible. This suggests the reproduction of this study considering male individuals, since a differential CVR seems to be present between genders.</p>
      </sec>
      <sec>
        <title>Final considerations and conclusions</title>
        <p>The prevention of CVD represents a public health challenge, since the development of these diseases involves the exposure to multiple risk factors, many of them closely related to living conditions and habits whose consequences arise in the long term. This is especially worrisome in the population analyzed in this study, considering the precarious conditions in which they live.</p>
        <p>This study will contribute to the identification of the most adequate instrument for defining high CVR and classifying the individuals most exposed to the synergism between risk factors, favoring the implementation of measures to reduce CVD morbidity and mortality.</p>
        <p>According to the results presented by this study, we conclude that the studied women presented a high prevalence of cardiovascular risk factors and that, in the absence of data on TC and HDL, the sGRS can be used without prejudice as a tool for screening those with high CVR.</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure" id="fn1">
        <p>
          <bold>Sources of Funding</bold>
        </p>
        <p>This study was partially funded by <italic>Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico</italic> - CNPq (National Council for Scientific and Technological Development), processes 442063/2014-8 e 466718/2014-4, and <italic>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Alagoas</italic> &#8211; FAPEAL (Research Support Foundation of the State of Alagoas), process 60030.000849/2016).</p>
      </fn>
      <fn fn-type="other" id="fn2">
        <p>
          <bold>Study Association</bold>
        </p>
        <p>This article is part of the thesis of master submitted by Andressa Lima Cavalcante, from <italic>Faculdade de Nutri&#231;&#227;o da Universidade Federal de Alagoas</italic>.</p>
      </fn>
      <fn fn-type="other" id="fn3">
        <p>
          <bold>Ethics approval and consent to participate</bold>
        </p>
        <p>This study was approved by the Ethics Committee of the <italic>Universidade Federal de Alagoas</italic> under the protocol number <italic>CAAE n&#186; 33527214.0.0000.5013</italic>. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barroso</surname>
              <given-names>WKS</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>CIS</given-names>
            </name>
            <name>
              <surname>Bortolotto</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Mota-Gomes</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Feitosa</surname>
              <given-names>ADM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brazilian Guidelines of Hypertension - 2020</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2021</year>
          <volume>116</volume>
          <issue>3</issue>
          <fpage>516</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="doi">10.36660/abc.20201238</pub-id>
        </element-citation>
        <mixed-citation>1. Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brand&#227;o AA, Feitosa ADM, et al. Brazilian Guidelines of Hypertension - 2020. Arq Bras Cardiol. 2021;116(3):516-658. doi: 10.36660/abc.20201238.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pr&#233;coma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GMM</given-names>
            </name>
            <name>
              <surname>Sim&#227;o</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Dutra</surname>
              <given-names>OP</given-names>
            </name>
            <name>
              <surname>Coelho</surname>
              <given-names>OR</given-names>
            </name>
            <name>
              <surname>Izar</surname>
              <given-names>MCO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atualiza&#231;&#227;o da Diretriz de Preven&#231;&#227;o Cardiovascular da Sociedade Brasileira de Cardiologia &#8211; 2019</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>113</volume>
          <issue>4</issue>
          <fpage>787</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="doi">10.5935/abc.20190204</pub-id>
        </element-citation>
        <mixed-citation>2. Pr&#233;coma DB, Oliveira GMM, Sim&#227;o AF, Dutra OP, Coelho OR, Izar MCO, et al. Atualiza&#231;&#227;o da Diretriz de Preven&#231;&#227;o Cardiovascular da Sociedade Brasileira de Cardiologia &#8211; 2019. Arq Bras Cardiol. 2019; 113(4):787-891. doi: 10.5935/abc.20190204.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Agostino</surname>
              <given-names>RB</given-names>
              <suffix>Sr</suffix>
            </name>
            <name>
              <surname>Vasan</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Pencina</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Cobain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Massaro</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study</article-title>
          <source>Circulation</source>
          <year>2008</year>
          <volume>117</volume>
          <issue>6</issue>
          <fpage>743</fpage>
          <lpage>753</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.699579</pub-id>
        </element-citation>
        <mixed-citation>3. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation. 2008;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)</collab>
          </person-group>
          <article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title>
          <source>Circulation</source>
          <year>2002</year>
          <volume>106</volume>
          <issue>25</issue>
          <fpage>3143</fpage>
          <lpage>3421</lpage>
        </element-citation>
        <mixed-citation>4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>SKM</given-names>
            </name>
            <name>
              <surname>Caldeira</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Fatores de Risco para Doen&#231;as Cr&#244;nicas N&#227;o Transmiss&#237;veis em Quilombolas do Norte de Minas Gerais</article-title>
          <source>Cadernos Sa&#250;de Coletiva</source>
          <year>2016</year>
          <volume>24</volume>
          <fpage>420</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="doi">10.1590/1414-462x201600040093</pub-id>
        </element-citation>
        <mixed-citation>5. Oliveira SKM, Caldeira AP. Fatores de Risco para Doen&#231;as Cr&#244;nicas N&#227;o Transmiss&#237;veis em Quilombolas do Norte de Minas Gerais. Cadernos Sa&#250;de Coletiva. 2016;24:420-7. doi: 10.1590/1414-462x201600040093.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barbosa</surname>
              <given-names>MCL</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Guerra</surname>
              <given-names>LFA</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>MFL</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>RL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dyslipidemia and Cardiovascular Risk in Afro-Descendants: A Study of the Quilombola Communities in Maranh&#227;o, Brazil</article-title>
          <source>Rev. Bras. Med. Fam. Comunidade</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>36</issue>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.5712/rbmfc10(36)925</pub-id>
        </element-citation>
        <mixed-citation>6. Barbosa MCL, Barbosa JB, Guerra LFA, Barbosa MFL, Barbosa FL, Barbosa RL, et al. Dyslipidemia and Cardiovascular Risk in Afro-Descendants: A Study of the Quilombola Communities in Maranh&#227;o, Brazil. Rev. Bras. Med. Fam. Comunidade. 2015;10(36):1-10. doi: 10.5712/rbmfc10(36)925</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Alagoas</collab>
          </person-group>
          <chapter-title>Secretaria de Estado do Planejamento, Gest&#227;o e Patrim&#244;nio</chapter-title>
          <source>Estudo Sobre as Comunidades Quilombolas de Alagoas</source>
          <publisher-loc>Macei&#243;</publisher-loc>
          <publisher-name>SEPLAG</publisher-name>
          <year>2015</year>
        </element-citation>
        <mixed-citation>7. Alagoas. Secretaria de Estado do Planejamento, Gest&#227;o e Patrim&#244;nio. Estudo Sobre as Comunidades Quilombolas de Alagoas. Macei&#243;: SEPLAG; 2015.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Associa&#231;&#227;o Brasileira de Empresas de Pesquisa (ABEP)</collab>
          </person-group>
          <chapter-title>Crit&#233;rio de Classifica&#231;&#227;o Econ&#244;mica Brasil</chapter-title>
          <source>Altera&#231;&#245;es na Aplica&#231;&#227;o do Crit&#233;rio Brasil</source>
          <comment>V&#225;lidas a Partir de 01/06/2019</comment>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>ABEP</publisher-name>
          <year>2019</year>
        </element-citation>
        <mixed-citation>8. Associa&#231;&#227;o Brasileira de Empresas de Pesquisa (ABEP). Crit&#233;rio de Classifica&#231;&#227;o Econ&#244;mica Brasil. Altera&#231;&#245;es na Aplica&#231;&#227;o do Crit&#233;rio Brasil, V&#225;lidas a Partir de 01/06/2019. S&#227;o Paulo: ABEP; 2019.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segall-Corr&#234;a</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Marin-Le&#243;n</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Melgar-Qui&#241;onez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>P&#233;rez-Escamilla</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Refinement of the Brazilian Household Food Insecurity Measurement Scale: Recommendation for a 14-item EBIA</article-title>
          <source>Revista de Nutri&#231;&#227;o</source>
          <year>2014</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>241</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="doi">10.1590/1415-52732014000200010</pub-id>
        </element-citation>
        <mixed-citation>9. Segall-Corr&#234;a AM, Marin-Le&#243;n L, Melgar-Qui&#241;onez H, P&#233;rez-Escamilla R. Refinement of the Brazilian Household Food Insecurity Measurement Scale: Recommendation for a 14-item EBIA. Revista de Nutri&#231;&#227;o 2014;27(2):241-51. doi:10.1590/1415-52732014000200010.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Foss-Freita</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Montenegro</surname>
              <given-names>RM</given-names>
              <suffix>Junior</suffix>
            </name>
            <name>
              <surname>Vencio</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <source>Diretrizes da Sociedade Brasileira de Diabetes 2017-2018</source>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>Editora Clannad</publisher-name>
          <year>2017</year>
        </element-citation>
        <mixed-citation>10. Oliveira JE, Foss-Freita MC, Montenegro Junior RM, Vencio S. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018. S&#227;o Paulo: Editora Clannad; 2017.</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faludi</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Izar</surname>
              <given-names>MCO</given-names>
            </name>
            <name>
              <surname>Saraiva</surname>
              <given-names>JFK</given-names>
            </name>
            <name>
              <surname>Chacra</surname>
              <given-names>APM</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Afiune</surname>
              <given-names>A</given-names>
              <suffix>Neto</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Atualiza&#231;&#227;o da Diretriz Brasileira de Dislipidemias e Preven&#231;&#227;o da Aterosclerose &#8211; 2017</article-title>
          <source>Arquivos Brasileiros de Cardiologia</source>
          <year>2017</year>
          <volume>109</volume>
          <issue>2</issue>
          <supplement>Supl.1</supplement>
          <fpage>1</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.5935/abc.20170121</pub-id>
        </element-citation>
        <mixed-citation>11. Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A, et al. Atualiza&#231;&#227;o da Diretriz Brasileira de Dislipidemias e Preven&#231;&#227;o da Aterosclerose &#8211; 2017. Arquivos Brasileiros de Cardiologia. 2017;109(2 Supl.1):1-76. doi: 10.5935/abc.20170121.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scartezini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>CEDS</given-names>
            </name>
            <name>
              <surname>Izar</surname>
              <given-names>MCO</given-names>
            </name>
            <name>
              <surname>Bertoluci</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vencio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Campana</surname>
              <given-names>GA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Positioning about the Flexibility of Fasting for Lipid Profiling</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2017</year>
          <volume>108</volume>
          <issue>3</issue>
          <fpage>195</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="doi">10.5935/abc.20170039</pub-id>
        </element-citation>
        <mixed-citation>12. Scartezini M, Ferreira CEDS, Izar MCO, Bertoluci M, Vencio S, Campana GA, et al. Positioning about the Flexibility of Fasting for Lipid Profiling. Arq Bras Cardiol. 2017;108(3):195-7. doi: 10.5935/abc.20170039.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henrique</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Micheli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lacerda</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Lacerda</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Formigoni</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Validation of the Brazilian version of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)</article-title>
          <source>Rev Assoc Med Bras</source>
          <year>2004</year>
          <volume>50</volume>
          <issue>2</issue>
          <fpage>199</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="doi">10.1590/s0104-42302004000200039</pub-id>
        </element-citation>
        <mixed-citation>13. Henrique IF, Micheli D, Lacerda RB, Lacerda LA, Formigoni ML. Validation of the Brazilian version of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Rev Assoc Med Bras. 2004;50(2):199-206. doi: 10.1590/s0104-42302004000200039.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>Obesity: Preventing and Managing the Global Epidemic - Report of a WHO Consultation</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
          <year>2000</year>
        </element-citation>
        <mixed-citation>14. World Health Organization. Obesity: Preventing and Managing the Global Epidemic - Report of a WHO Consultation. Geneva: World Health Organization; 2000.</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>D'Agostino</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Belanger</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Silbershatz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kannel</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
          <article-title>Prediction of Coronary Heart Disease Using Risk Factor Categories</article-title>
          <source>Circulation</source>
          <year>1998</year>
          <volume>97</volume>
          <issue>18</issue>
          <fpage>1837</fpage>
          <lpage>1847</lpage>
          <pub-id pub-id-type="doi">10.1161/01.cir.97.18.1837</pub-id>
        </element-citation>
        <mixed-citation>15. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998;97(18):1837-47. doi: 10.1161/01.cir.97.18.1837.</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Cadernos de Aten&#231;&#227;o B&#225;sica n. 14: Preven&#231;&#227;o Cl&#237;nica de Doen&#231;a Cardiovascular, Cerebrovascular e Renal Cr&#244;nica</source>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Minist&#233;rio da Sa&#250;de</publisher-name>
          <year>2006</year>
        </element-citation>
        <mixed-citation>16. Brasil. Minist&#233;rio da Sa&#250;de. Cadernos de Aten&#231;&#227;o B&#225;sica n. 14: Preven&#231;&#227;o Cl&#237;nica de Doen&#231;a Cardiovascular, Cerebrovascular e Renal Cr&#244;nica. Bras&#237;lia: Minist&#233;rio da Sa&#250;de; 2006.</mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Cadernos de Aten&#231;&#227;o B&#225;sica n. 37: Estrat&#233;gias para o Cuidado da Pessoa com Doen&#231;a Cr&#244;nica - Hipertens&#227;o Arterial</source>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Minist&#233;rio da Sa&#250;de;</publisher-name>
          <year>2014</year>
        </element-citation>
        <mixed-citation>17. Brasil. Minist&#233;rio da Sa&#250;de. Cadernos de Aten&#231;&#227;o B&#225;sica n. 37: Estrat&#233;gias para o Cuidado da Pessoa com Doen&#231;a Cr&#244;nica - Hipertens&#227;o Arterial. Bras&#237;lia: Minist&#233;rio da Sa&#250;de; 2014.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>ARB</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Siqueira</surname>
              <given-names>YMC</given-names>
            </name>
            <name>
              <surname>Zoboli</surname>
              <given-names>ELCP</given-names>
            </name>
            <name>
              <surname>Fracolli</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>A Educa&#231;&#227;o em Sa&#250;de no Cuidado de Usu&#225;rios do Programa Automonitoramento Glic&#234;mico</article-title>
          <source>Rev Esc Enferm USP</source>
          <year>2012</year>
          <volume>46</volume>
          <fpage>761</fpage>
          <lpage>765</lpage>
          <pub-id pub-id-type="doi">10.1590/S0080-62342012000300031</pub-id>
        </element-citation>
        <mixed-citation>18. Matsumoto PM, Barreto ARB, Sakata KN, Siqueira YMC, Zoboli ELCP, Fracolli LA. A Educa&#231;&#227;o em Sa&#250;de no Cuidado de Usu&#225;rios do Programa Automonitoramento Glic&#234;mico. Rev Esc Enferm USP. 2012;46:761-5. doi :10.1590/S0080-62342012000300031.</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Cadernos de Aten&#231;&#227;o B&#225;sica n. 36: Estrat&#233;gias para o Cuidado da Pessoa com Doen&#231;a Cr&#244;nica - Diabetes Mellitus</source>
          <publisher-loc>Bras&#237;lia (DF)</publisher-loc>
          <publisher-name>Minist&#233;rio da Sa&#250;de;</publisher-name>
          <year>2013</year>
        </element-citation>
        <mixed-citation>19. Brasil. Minist&#233;rio da Sa&#250;de. Cadernos de Aten&#231;&#227;o B&#225;sica n. 36: Estrat&#233;gias para o Cuidado da Pessoa com Doen&#231;a Cr&#244;nica - Diabetes Mellitus. Bras&#237;lia (DF): Minist&#233;rio da Sa&#250;de; 2013.</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>ZM</given-names>
            </name>
          </person-group>
          <article-title>Comunidade quilombola na Regi&#227;o Nordeste do Brasil: Sa&#250;de de Mulheres e Crian&#231;as Antes e Ap&#243;s sua Certifica&#231;&#227;o</article-title>
          <source>Revista Brasileira de Sa&#250;de Materno Infantil</source>
          <year>2015</year>
          <volume>15</volume>
          <fpage>219</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="doi">10.1590/S1519-38292015000200008</pub-id>
        </element-citation>
        <mixed-citation>20. Ferreira HS, Torres ZM. Comunidade quilombola na Regi&#227;o Nordeste do Brasil: Sa&#250;de de Mulheres e Crian&#231;as Antes e Ap&#243;s sua Certifica&#231;&#227;o. Revista Brasileira de Sa&#250;de Materno Infantil. 2015;15:219-29. doi:10.1590/S1519-38292015000200008.</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>EKP</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>R&#234;go</surname>
              <given-names>MAS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Food Insecurity in Rural Communities in Northeast Brazil: Does Belonging to a Slave-Descendent Community Make a Difference?</article-title>
          <source>Cad Saude Publica</source>
          <year>2017</year>
          <volume>33</volume>
          <issue>4</issue>
          <elocation-id>e00005716</elocation-id>
          <pub-id pub-id-type="doi">10.1590/0102-311x5716</pub-id>
        </element-citation>
        <mixed-citation>21. Silva EKP, Medeiros DS, Martins PC, Sousa LA, Lima GP, R&#234;go MAS, et al. Food Insecurity in Rural Communities in Northeast Brazil: Does Belonging to a Slave-Descendent Community Make a Difference?. Cad Saude Publica. 2017;33(4):e00005716. doi: 10.1590/0102-311x5716.</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>WO</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Bezerra</surname>
              <given-names>MKA</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>BCV</given-names>
            </name>
            <name>
              <surname>Horta</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
          <article-title>Body Composition and Hypertension: A Comparative Study Involving Women from Maroon Communities and from the General Population of Alagoas State, Brazil</article-title>
          <source>Rev Nutr</source>
          <year>2013</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>539</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="doi">10.1590/S1415-52732013000500005</pub-id>
        </element-citation>
        <mixed-citation>22. Ferreira HS, Silva WO, Santos EA, Bezerra MKA, Silva BCV, Horta BL. Body Composition and Hypertension: A Comparative Study Involving Women from Maroon Communities and from the General Population of Alagoas State, Brazil. Rev Nutr. 2013;26(5):539-49. doi: 10.1590/S1415-52732013000500005.</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendon&#231;a</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Pimenta</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Gea</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martinez-Gonzalez</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bes-Rastrollo</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Ultra-Processed Food Consumption and the Incidence of Hypertension in a Mediterranean Cohort: The Seguimiento Universidad de Navarra Project</article-title>
          <source>Am J Hypertens</source>
          <year>2017</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>358</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="doi">10.1093/ajh/hpw137</pub-id>
        </element-citation>
        <mixed-citation>23. Mendon&#231;a RD, Lopes AC, Pimenta AM, Gea A, Martinez-Gonzalez MA, Bes-Rastrollo M. Ultra-Processed Food Consumption and the Incidence of Hypertension in a Mediterranean Cohort: The Seguimiento Universidad de Navarra Project. Am J Hypertens. 2017;30(4):358-366. doi: 10.1093/ajh/hpw137.</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Facchini</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Tomasi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dil&#233;lio</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Qualidade da Aten&#231;&#227;o Prim&#225;ria &#224; Sa&#250;de no Brasil: Avan&#231;os, Desafios e Perspectivas</article-title>
          <source>Sa&#250;de Debate</source>
          <year>2018</year>
          <volume>42</volume>
          <issue>1</issue>
          <fpage>208</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="doi">10.1590/0103-11042018S114</pub-id>
        </element-citation>
        <mixed-citation>24. Facchini LA, Tomasi E, Dil&#233;lio AS. Qualidade da Aten&#231;&#227;o Prim&#225;ria &#224; Sa&#250;de no Brasil: Avan&#231;os, Desafios e Perspectivas. Sa&#250;de Debate. 2018;42(1):208-23. doi: 10.1590/0103-11042018S114</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cuevas</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rodgers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>De Nufrio</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Alley</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Developmental Timing of Initial Racial Discrimination Exposure is Associated With Cardiovascular Health Conditions in Adulthood</article-title>
          <source>Ethn Health</source>
          <year>2019</year>
          <fpage>1</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1080/13557858.2019.1613517</pub-id>
        </element-citation>
        <mixed-citation>25. Cuevas AG, Ho T, Rodgers J, DeNufrio D, Alley L, Allen J, et al. Developmental Timing of Initial Racial Discrimination Exposure is Associated With Cardiovascular Health Conditions in Adulthood. Ethn Health. 2019:1-14. doi: 10.1080/13557858.2019.1613517.</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paradies</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ben</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Denson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Elias</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Priest</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pieterse</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Racism as a Determinant of Health: A Systematic Review and Meta-Analysis</article-title>
          <source>PLoS One</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>9</issue>
          <elocation-id>e0138511</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0138511</pub-id>
        </element-citation>
        <mixed-citation>26. Paradies Y, Ben J, Denson N, Elias A, Priest N, Pieterse A, et al. Racism as a Determinant of Health: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(9):e0138511. doi: 10.1371/journal.pone.0138511.</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Priest</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Racismo e Sa&#250;de: Um Corpus Crescente de Evid&#234;ncia Internacional</article-title>
          <source>Sociologias</source>
          <year>2015</year>
          <volume>17</volume>
          <issue>40</issue>
          <fpage>124</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="doi">10.1590/15174522-017004004</pub-id>
        </element-citation>
        <mixed-citation>27. Williams DR, Priest N. Racismo e Sa&#250;de: Um Corpus Crescente de Evid&#234;ncia Internacional. Sociologias. 2015;17(40):124-74. doi: 10.1590/15174522-017004004.</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freitas</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Caballero</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Hern&#225;ndez</surname>
              <given-names>CIV</given-names>
            </name>
            <name>
              <surname>Antunes</surname>
              <given-names>SLNO</given-names>
            </name>
          </person-group>
          <article-title>Sa&#250;de e Comunidades Quilombolas: Uma Revis&#227;o da Literatura</article-title>
          <source>Rev CEFAC</source>
          <year>2011</year>
          <volume>13</volume>
          <issue>5</issue>
          <fpage>937</fpage>
          <lpage>943</lpage>
          <pub-id pub-id-type="doi">10.1590/S1516-18462011005000033</pub-id>
        </element-citation>
        <mixed-citation>28. Freitas DA, Caballero AD, Marques AS, Hern&#225;ndez CIV, Antunes SLNO. Sa&#250;de e Comunidades Quilombolas: Uma Revis&#227;o da Literatura. Rev CEFAC. 2011;13(5):937-43. doi: 10.1590/S1516-18462011005000033.</mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="thesis">
          <person-group person-group-type="author">
            <name>
              <surname>Neiva</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <source>Sa&#250;de Mental Materna e Estado Nutricional do Bin&#244;mio M&#227;e/Filho na Popula&#231;&#227;o Quilombola de Alagoas [dissertation]</source>
          <publisher-loc>Macei&#243;</publisher-loc>
          <publisher-name>Universidade Federal de Alagoas;</publisher-name>
          <year>2010</year>
        </element-citation>
        <mixed-citation>29. Neiva GS. Sa&#250;de Mental Materna e Estado Nutricional do Bin&#244;mio M&#227;e/Filho na Popula&#231;&#227;o Quilombola de Alagoas [dissertation]. Macei&#243;: Universidade Federal de Alagoas; 2010.</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Barbosa</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <source>Sa&#250;de Mental de Mulheres Segundo a Condi&#231;&#227;o de (In)Seguran&#231;a Alimentar: Estudo de Base Populacional no Estado de ALAGOAS. 2017</source>
          <publisher-loc>Macei&#243;</publisher-loc>
          <publisher-name>Universidade Federal de Alagoas;</publisher-name>
          <year>2018</year>
        </element-citation>
        <mixed-citation>30. Barbosa RL. Sa&#250;de Mental de Mulheres Segundo a Condi&#231;&#227;o de (In)Seguran&#231;a Alimentar: Estudo de Base Populacional no Estado de ALAGOAS. 2017. Macei&#243;: Universidade Federal de Alagoas; 2018.</mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Plano de Reorganiza&#231;&#227;o da Aten&#231;&#227;o &#224; Hipertens&#227;o Arterial e ao Diabetes mellitus: Manual de Hipertens&#227;o Arterial e Diabetes Mellitus</source>
          <publisher-loc>Bras&#237;lia (DF)</publisher-loc>
          <publisher-name>Minist&#233;rio da Sa&#250;de;</publisher-name>
          <year>2001</year>
        </element-citation>
        <mixed-citation>31. Brasil. Minist&#233;rio da Sa&#250;de. Plano de Reorganiza&#231;&#227;o da Aten&#231;&#227;o &#224; Hipertens&#227;o Arterial e ao Diabetes mellitus: Manual de Hipertens&#227;o Arterial e Diabetes Mellitus. Bras&#237;lia (DF): Minist&#233;rio da Sa&#250;de; 2001.</mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Preven&#231;&#227;o Cl&#237;nica de Doen&#231;as Cardiovasculares, Cerebrovasculares e Renais</source>
          <publisher-loc>Bras&#237;lia (DF)</publisher-loc>
          <publisher-name>Minist&#233;rio da Sa&#250;de;</publisher-name>
          <year>2006</year>
        </element-citation>
        <mixed-citation>32. Brasil. Minist&#233;rio da Sa&#250;de. Preven&#231;&#227;o Cl&#237;nica de Doen&#231;as Cardiovasculares, Cerebrovasculares e Renais. Bras&#237;lia (DF): Minist&#233;rio da Sa&#250;de; 2006.</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kariuki</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Stuart-Shor</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Leveille</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Gona</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cromwell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hayman</surname>
              <given-names>LL</given-names>
            </name>
          </person-group>
          <article-title>Validation of the nonlaboratory-based Framingham cardiovascular disease risk assessment algorithm in the Atherosclerosis Risk in Communities dataset</article-title>
          <source>J Cardiovasc Med</source>
          <year>2017</year>
          <volume>18</volume>
          <issue>12</issue>
          <fpage>936</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="doi">10.2459/JCM.0000000000000583</pub-id>
        </element-citation>
        <mixed-citation>33. Kariuki JK, Stuart-Shor EM, Leveille SG, Gona P, Cromwell J, Hayman LL. Validation of the nonlaboratory-based Framingham cardiovascular disease risk assessment algorithm in the Atherosclerosis Risk in Communities dataset. J Cardiovasc Med. 2017;18(12):936-45. doi: 10.2459/JCM.0000000000000583.</mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foo</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Sundram</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Legido-Quigley</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Facilitators and Barriers of Managing Patients With Multiple Chronic Conditions in the Community: A Qualitative Study</article-title>
          <source>BMC Public Health</source>
          <year>2020</year>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>273</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="doi">10.1186/s12889-020-8375-8</pub-id>
        </element-citation>
        <mixed-citation>34. Foo KM, Sundram M, Legido-Quigley H. Facilitators and Barriers of Managing Patients With Multiple Chronic Conditions in the Community: A Qualitative Study. BMC Public Health. 2020;20(1):273. doi: 10.1186/s12889-020-8375-8.</mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomes</surname>
              <given-names>KO</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Cherchiglia</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Use of health services by quilombo communities in southwest Bahia State, Brazil</article-title>
          <source>Cad Saude Publica</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>9</issue>
          <fpage>1829</fpage>
          <lpage>1842</lpage>
          <pub-id pub-id-type="doi">10.1590/0102-311x151412</pub-id>
        </element-citation>
        <mixed-citation>35. Gomes KO, Reis EA, Guimar&#227;es MD, Cherchiglia ML. Use of health services by quilombo communities in southwest Bahia State, Brazil. Cad Saude Publica. 2013;29(9):1829-42. doi: 10.1590/0102-311x151412.</mixed-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vieira</surname>
              <given-names>ABD</given-names>
            </name>
            <name>
              <surname>Monteiro</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>Comunidade Quilombola: An&#225;lise do Problema Persistente do Acesso &#224; Sa&#250;de, sob o Enfoque da Bio&#233;tica de Interven&#231;&#227;o</article-title>
          <source>Saude Debate</source>
          <year>2013</year>
          <volume>37</volume>
          <issue>99</issue>
          <fpage>610</fpage>
          <lpage>618</lpage>
        </element-citation>
        <mixed-citation>36. Vieira ABD, Monteiro PS. Comunidade Quilombola: An&#225;lise do Problema Persistente do Acesso &#224; Sa&#250;de, sob o Enfoque da Bio&#233;tica de Interven&#231;&#227;o. Saude Debate. 2013;37(99):610-18.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
